Antimicrobial Resistance: The Musical
For the third annual Innovate4Outcomes®design-thinking event, our team chose to take on the global health concern of Antimicrobial Resistance, or AMR.
For the third annual Innovate4Outcomes®design-thinking event, our team chose to take on the global health concern of Antimicrobial Resistance, or AMR.
As medtech and medical device companies continue to advance their digital strategies, understanding and aligning with the digital patient journey have become more important...
Real-World Data (RWD) has become an essential element of pharmaceutical marketing, but as an industry, we are far from utilizing its full potential. During my recent session...
Innovate4Outcomes® is a design-thinking, half-day event that brings together those interested in cross-industry collaboration to brainstorm potential pathways to reduce the...
In almost every therapy area, utilization management, prior authorizations, and step therapy...
There are more than 100 different types of arthritis, but osteoarthritis (OA) is the most common—impacting 32.5 Million US adults and creating an overall economic burden of...
The 2022 State of Mental Health in America report highlights that 24.7% of adults with a mental illness in 2019 reported an unmet need for treatment—this number has seen a...
Despite incredible advances in the availability of real-world data (RWD) and AI applications, many tech-savvy brand...
In the quest to improve patient outcomes, life sciences companies are increasing their focus on optimizing the patient...
If you’re a life science marketer, chances are you’ve been hearing about the difference artificial...
Pharma manufacturers work relentlessly to create drugs and therapies to address some of the most complex health conditions people face. There are years of research and...
Innovate4Outcomes® was born in 2020 as a design-thinking event in response to COVID-19, but it quickly became clear the COVID-19 health crisis could be a catalyst for a...